|
Orthologous residues
|
|
MAP2 (human): T1616‑p, MAP2 iso2 (human): T260‑p, MAP2 iso3 (human): T1612‑p, MAP2 iso4 (human): T317‑p, MAP2 (mouse): T1620‑p, MAP2 iso2 (mouse): ‑, MAP2 iso6 (mouse): T259‑p, MAP2 (rat): T1622‑p, MAP2 iso2 (rat): T1622‑p, MAP2 iso3 (rat): T259‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
microscopy-colocalization with upstream kinase, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
COS (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
monkey
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
GSK3B (human)
|
phospho-antibody, transfection of inactive enzyme, transfection of wild-type enzyme, pharmacological inhibitor of upstream enzyme
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
cytoskeletal reorganization
|
|
Comments:
caused decrease in microtubule bundles
|
|
|